Investee Company News

June 21, 2017 Viamet to Present Data on VT-1161 for the Treatment of Onychomycosis at the 4th International Summit on Nail Diseases June 19, 2017 Melinta Therapeutics Announces U.S. FDA Approval of Baxdela™ (Delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) June 16, 2017 Kymab appoints Dr Martin Nicklasson as Non-Executive Chair June 14, 2017 Viamet to Participate in Antifungal Panel Discussion at the 2017 BIO International Convention June 13, 2017 Xenex Announces LightStrike Disinfection Pod™ – Industry’s First Mobile Equipment Disinfection System June 8, 2017 3D4Medical announces exclusive partnership with Sky June 5, 2017 Melinta Therapeutics Demonstrates Potential of Pyrrolocytosine Candidate against Gonorrhea June 5, 2017 Novan Announces Leadership Adjustments and Business Update June 5, 2017 Viamet’s VT-1598 Demonstrates Potent Activity Against Candida auris and Other Life-Threatening Fungal Species June 5, 2017 Poseida Therapeutics Presents High-Fidelity Genome Editing System for Production of Allogeneic “Universal Donor” CAR-T Cells at American Society of Clinical Oncology Annual Meeting June 5, 2017 Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting June 4, 2017 Viamet Presents Phase 2b Results Demonstrating Unprecedented Efficacy of Oral VT-1161 in the Treatment of Recurrent Vulvovaginal Candidiasis June 1, 2017 Melinta Therapeutics Presenting In Vivo and In Vitro Results from Baxdela Studies at ASM Microbe June 1, 2017 Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting May 23, 2017 Teneobio and Poseida Announce License Agreement for the Use of UniDab™ in CAR T-Cell Therapy May 17, 2017 Viamet Data for VT-1161 and VT-1598 to be Presented at The American Society for Microbiology’s ASM Microbe 2017 Conference May 12, 2017 Novan Reports First Quarter 2017 Financial Results May 12, 2017 Abbas Hussain Joins the Board of Immunocore as Non-Executive Director May 9, 2017 3D4Medical Launches Complete Ortho – its Latest Clinical App for iPhone and iPad May 9, 2017 Kymab appoints Dr Sonia Quaratino as Chief Medical Officer May 8, 2017 Immunocore identifies second novel ImmTAC® in the GSK collaboration May 2, 2017 Melinta Therapeutics’ Phase 3 trials of Baxdela Document Challenges in Antibiotic Selection in Patients Treated for ABSSSI April 27, 2017 Novan Presents Safety Data for SB204 Program April 27, 2017 Novan Presents Preclinical Data from Inflammatory Skin Diseases Program April 21, 2017 Melinta Therapeutics Updates Pyrrolocytosine and Enhanced Macrolide Programs at ECCMID Showcasing Company’s Structure-Based Drug Design April 21, 2017 Melinta Therapeutics Presentations at ECCMID Show Potential of Baxdela in Obese and other Challenging Patient Types April 19, 2017 Melinta Therapeutics Highlighting Activity of Baxdela as well as Progress on Macrolide and Pyrrolocytosine Candidates at ECCMID 2017 April 12, 2017 Novan Reports Positive Topline Results with SB208 in Phase 2 Trial April 4, 2017 Novan Welcomes Key Opinion Leaders to New Advisory Council April 4, 2017 Poseida Therapeutics Presents Preclinical Data Demonstrating Multiple Therapeutic Advantages from BCMA-Specific CAR-T Program at AACR